| 1 |
human aortic smooth muscle cells
(388 times)
|
Vascular Diseases
(62 times)
|
VSMCs (45 times)
HUVECs (33 times)
NF-kappaB (21 times)
|
1991 Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells.
|
| 2 |
human aortic SMCs
(30 times)
|
Vascular Diseases
(8 times)
|
SMCs (16 times)
VSMCs (8 times)
AD (3 times)
|
1995 Human Aortic Vascular Smooth Muscle Cells Digest Extracellular Matrix by Elaboration of Plasminogen Activators: Implications for Atherogenesis.
|
| 3 |
human ASM cells
(4 times)
|
Pulmonary Medicine
(2 times)
|
ASM (4 times)
EdU (1 time)
HLMCs (1 time)
|
2006 Role of transient receptor potential C3 in TNF-alpha-enhanced calcium influx in human airway myocytes.
|
| 4 |
human ASMCs
(4 times)
|
Pulmonary Medicine
(1 time)
|
ASMCs (3 times)
PDGF (2 times)
ASMC (1 time)
|
2012 Nanomolar ouabain increases NCX1 expression and enhances Ca2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance?
|
| 5 |
human artery VSMCs
(1 time)
|
Molecular Biology
(1 time)
|
LEAOD (1 time)
VSMCs (1 time)
|
2020 TIM‑3 inhibits PDGF‑BB‑induced atherogenic responses in human artery vascular smooth muscle cells.
|
| 6 |
human blood vessel smooth muscle cells
(1 time)
|
Molecular Biology
(1 time)
|
PDE3 (1 time)
PDEs (1 time)
|
2000 Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues.
|
A Search Service for Abbreviation / Long Form